Please Wait.....
Report
Global Multiomics Market
Market Research Report I 2024-09-06 I 149 Pages I BCC Research
Description
Report Scope:
This report covers the global market for multiomics segments based on products, platforms, applications, end-users, and regions. This research report incorporates an in-depth analysis of the multiomics market, including market estimations and trends through 2029. By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.
Major players, products, platforms, applications, market dynamics, and geographic opportunities are discussed in detail in the report. This report also examines various analytical frameworks such as PESTEL analysis, ESG analysis, competitive analysis, and strategic recommendations, which will aid the companies in devising their strategic plan of action.
Report Includes:
- 51 data tables and 55 additional tables
- An analysis of the current and future global markets for multiomics
- Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the market size and revenue forecasts for the global multiomics market, with market share analysis by product, type, platform, end-user, application and region
- Discussion of the applications of multiomics in research studies such as analyzing many omics datasets, integrating data from genomes, transcriptomics, epigenetics, and proteomics. This in turn provides more precise information to identify causal alterations, and by exposing the etiology of the disease, can lead to the possible treatment options
- Discussions of the market dynamics, opportunities, and challenges, as well as emerging technologies
- Overview of sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
- Competitive intelligence, including companies' market shares, recent M&A activity, and venture funding.
- Profiles of the leading companies, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., and F. Hoffman-La Roche Ltd.
Executive Summary
Summary:
Multiple omics, or multiomics, offer an integrated method for power discovery at several biological levels. By integrating data from several fields, including genomes, transcriptomics, epigenetics, and proteomics, scientists may comprehensively understand the molecular alterations contributing to typical development, cellular response, and illness. The therapeutics development process is witnessing significant transition toward a more comprehensive and holistic understanding of the disease microenvironment from a simplified and genomic-focused approach, thus creating a massive demand for multiomics technologies. Multiomics is a relatively emerging field with tremendous growth potential due to its promising applications. Established players have already entered the market by introducing multiomics products, software and services.
The multiomics market is set to gain momentum due to the adoption of multiomics technologies and products in various fields, including biomedical research and pharmaceutical development, coupled with increasing research investments, expanding applications across multiple sectors, collaborative initiatives, and technological advancements.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Technology Background
Omics Types
Various Multiomics Approaches and Applications
Technological Infrastructure and Data Integration
PESTEL Analysis
Political
Economic
Social
Technological
Environmental
Legal
Regulatory Landscape
Federal Regulation
CMS Regulation
U.S. Food and Drug Administration Regulation
U.S. Federal Trade Commission Regulation
Strategic Recommendations
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rapid Advances in Multiomics Research and its Applications
Favorable Funding Scenario for Multiomics Research Activities
Decrease in DNA-Sequencing Method Prices
Growing Prevalence of Cancer Generating Demand for Personalized Treatments
Promising Applications of Multiomics in the Drug Development Process
Market Restraints
Lack of Data Standardization
Market Opportunities
Expanding Single-Cell Multiomics Applications
Chapter 4 Emerging Technologies and Developments
Artificial Intelligence in Multiomics
Companies in the Artificial Intelligence Multiomics Market
Advances in Single-Cell Omics and Multiomics
Chapter 5 Market Segmentation Analysis
Key Market Trends
Segmentation Breakdown
Global Market for Multiomics by Product
Instruments
Consumables
Software and Services
Global Market for Multiomics by Platform
Genomics
Proteomics
Transcriptomics
Metabolomics
Other Platforms
Global Market for Multiomics by Application
Oncology
Immunology
Neurology
Cell Biology
Other Applications
Global Market for Multiomics by End User
Academic Research Organizations
Pharmaceutical and Biotechnology Companies
Clinical and Hospital Laboratories
Other End Users
Geographic Breakdown
Global Multiomics Market by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Top Players Ranking
Key Strategies Adopted by Players
Collaborations and Partnerships
New Product Launches
Expansions and Investments
Mergers and Acquisitions
Agreements
Patent Analysis
Chapter 7 Sustainability in Multiomics Market: ESG Perspective
Introduction to ESG
ESG Performance in Market
ESG Practices in the Multiomics Industry
Concluding Remarks from BCC Research
Chapter 8 Appendix
Methodology
Acronyms
References
Company Profiles
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
BIO-RAD LABORATORIES INC.
BD
BRUKER
BGI
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
QIAGEN
REVVITY
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table A : Global Market for Multiomics, by Product, Through 2029
Summary Table B : Global Market for Multiomics, by Region, Through 2029
Table 1 : Multiomics Approaches and Their Molecular Readouts
Table 2 : Molecular Biology Technologies for Multiomics Approaches
Table 3 : Single-Cell and Spatial Omics Technologies, 2018-2023
Table 4 : Publicly Available Omics Data in the Cancer Research Field
Table 5 : Multiomics' Role During Various Stages of Drug Development Process
Table 6 : Companies in the Artificial Intelligence Multiomics Market
Table 7 : Global Market for Multiomics, by Product, Through 2029
Table 8 : Global Market for Multiomics for Instruments, by Region, Through 2029
Table 9 : Global Market for Multiomics for Consumables, by Region, Through 2029
Table 10 : Global Market for Multiomics for Software and Services, by Region, Through 2029
Table 11 : Global Market for Multiomics, by Platform, Through 2029
Table 12 : Global Market for Multiomics for Genomics, by Region, Through 2029
Table 13 : Global Market for Multiomics for Proteomics, by Region, Through 2029
Table 14 : Global Market for Multiomics for Transcriptomics, by Region, Through 2029
Table 15 : Global Market for Multiomics for Metabolomics, by Region, Through 2029
Table 16 : Global Market for Multiomics for Other Platforms, by Region, Through 2029
Table 17 : Global Market for Multiomics, by Application, Through 2029
Table 18 : Global Market for Multiomics for Oncology, by Region, Through 2029
Table 19 : Global Market for Multiomics for Immunology, by Region, Through 2029
Table 20 : Global Market for Multiomics for Neurology, by Region, Through 2029
Table 21 : Global Market for Multiomics for Cell Biology, by Region, Through 2029
Table 22 : Global Market for Multiomics for Other Applications, by Region, Through 2029
Table 23 : Global Market for Multiomics, by End User, Through 2029
Table 24 : Global Market for Multiomics for Academic Research Organizations, by Region, Through 2029
Table 25 : Global Market for Multiomics for Pharmaceutical and Biotechnology Companies, by Region, Through 2029
Table 26 : Global Market for Multiomics for Clinical and Hospital Laboratories, by Region, Through 2029
Table 27 : Global Market for Multiomics for Other End Users, by Region, Through 2029
Table 28 : Global Market for Multiomics, by Region, Through 2029
Table 29 : North American Market for Multiomics, by Product, Through 2029
Table 30 : North American Market for Multiomics, by Platform, Through 2029
Table 31 : North American Market for Multiomics, by Application, Through 2029
Table 32 : North American Market for Multiomics, by End User, Through 2029
Table 33 : European Initiatives Focused on Omics Research for Personalized Medicine
Table 34 : European Market for Multiomics, by Product, Through 2029
Table 35 : European Market for Multiomics, by Platform, Through 2029
Table 36 : European Market for Multiomics, by Application, Through 2029
Table 37 : European Market for Multiomics, by End User, Through 2029
Table 38 : Asia-Pacific Market for Multiomics, by Product, Through 2029
Table 39 : Asia-Pacific Market for Multiomics, by Platform, Through 2029
Table 40 : Asia-Pacific Market for Multiomics, by Application, Through 2029
Table 41 : Asia-Pacific Market for Multiomics, by End User, Through 2029
Table 42 : Rest of the World Market for Multiomics, by Product, Through 2029
Table 43 : Rest of the World Market for Multiomics, by Platform, Through 2029
Table 44 : Rest of the World Market for Multiomics, by Application, Through 2029
Table 45 : Rest of the World Market for Multiomics, by End User, Through 2029
Table 46 : Top Players in Multiomics Market, 2023
Table 47 : Collaborations and Partnerships: Multiomics Market, 2021-2024
Table 48 : New Product Launches: Multiomics Market, 2021-2024
Table 49 : Expansions and Investments: Multiomics Market, 2021-2024
Table 50 : Mergers and Acquisitions: Multiomics Market, 2020-2024
Table 51 : Agreements: Multiomics Market, 2022-2024
Table 52 : Multiomics Market: Patent Analysis, 2018-2023
Table 53 : Key Focus Areas in ESG Metrics
Table 54 : Environmental Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 55 : Social Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 56 : Governance Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 57 : ESG Rankings for Multiomics Companies, 2024*
Table 58 : Acronyms Used in this Report
Table 59 : Agilent Technologies Inc.: Company Snapshot
Table 60 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 61 : Agilent Technologies Inc.: Product Portfolio
Table 62 : Agilent Technologies Inc.: News/Key Developments, 2023
Table 63 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot
Table 64 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio
Table 65 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2023
Table 66 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 67 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 68 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 69 : Bio-Rad Laboratories Inc.: News/Key Developments, 2020
Table 70 : BD: Company Snapshot
Table 71 : BD: Financial Performance, FY 2022 and 2023
Table 72 : BD: Product Portfolio
Table 73 : BD: News/Key Developments, 2024
Table 74 : Bruker: Company Snapshot
Table 75 : Bruker: Financial Performance, FY 2022 and 2023
Table 76 : Bruker: Product Portfolio
Table 77 : Bruker: News/Key Developments, 2024
Table 78 : BGI: Company Snapshot
Table 79 : BGI: Product Portfolio
Table 80 : BGI: News/Key Developments, 2024
Table 81 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 82 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 83 : F. Hoffman-La Roche Ltd.: Product Portfolio
Table 84 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2022
Table 85 : Illumina Inc.: Company Snapshot
Table 86 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 87 : Illumina Inc.: Product Portfolio
Table 88 : Illumina Inc.: News/Key Developments, 2023
Table 89 : QIAGEN: Company Snapshot
Table 90 : QIAGEN: Financial Performance, FY 2022 and 2023
Table 91 : QIAGEN: Product Portfolio
Table 92 : QIAGEN: News/Key Developments, 2024
Table 93 : Revvity: Company Snapshot
Table 94 : Revvity: Financial Performance, FY 2022 and 2023
Table 95 : Revvity: Product Portfolio
Table 96 : Revvity: News/Key Developments, 2023
Table 97 : Standard BioTools: Company Snapshot
Table 98 : Standard BioTools: Financial Performance, FY 2022 and 2023
Table 99 : Standard BioTools: Product Portfolio
Table 100 : Standard BioTools: News/Key Developments, 2024
Table 101 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 102 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 103 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 104 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024
List of Figures
Summary Figure A : Global Market for Multiomics, by Product, 2021-2029
Summary Figure B : Global Market for Multiomics, by Region, 2021-2029
Figure 1 : Omics Types
Figure 2 : Applications of Multiomics Approaches
Figure 3 : PESTEL Analysis: Multiomics Market
Figure 4 : Strategic Recommendations: Multiomics Market
Figure 5 : Multiomics Market Dynamics
Figure 6 : Average Cost Per Genome: Year-on-Year Trend, 2011-2022
Figure 7 : Global Market Shares for Multiomics, by Product, 2024
Figure 8 : Global Market for Multiomics for Instruments, by Region, 2021-2029
Figure 9 : Global Market for Multiomics for Consumables, by Region, 2021-2029
Figure 10 : Global Market for Multiomics for Software and Services, by Region, 2021-2029
Figure 11 : Global Market Shares for Multiomics, by Platform, 2024
Figure 12 : Global Market for Multiomics for Genomics, by Region, 2021-2029
Figure 13 : Global Market for Multiomics for Proteomics, by Region, 2021-2029
Figure 14 : Global Market for Multiomics for Transcriptomics, by Region, 2021-2029
Figure 15 : Global Market for Multiomics for Metabolomics, by Region, 2021-2029
Figure 16 : Global Market for Multiomics for Other Platforms, by Region, 2021-2029
Figure 17 : Major Applications of Multiomics
Figure 18 : Global Market Shares for Multiomics, by Application, 2024
Figure 19 : Global Market for Multiomics for Oncology, by Region, 2021-2029
Figure 20 : Global Market for Multiomics for Immunology, by Region, 2021-2029
Figure 21 : Global Market for Multiomics for Neurology, by Region, 2021-2029
Figure 22 : Global Market for Multiomics for Cell Biology, by Region, 2021-2029
Figure 23 : Global Market for Multiomics for Other Applications, by Region, 2021-2029
Figure 24 : Global Market Shares for Multiomics, by End User, 2024
Figure 25 : Global Market for Multiomics for Academic Research Organizations, by Region, 2021-2029
Figure 26 : Global Market for Multiomics for Pharmaceutical and Biotechnology Companies, by Region, 2021-2029
Figure 27 : Global Market for Multiomics for Clinical and Hospital Laboratories, by Region, 2021-2029
Figure 28 : Global Market for Multiomics for Other End Users, by Region, 2021-2029
Figure 29 : Global Market Shares of Multiomics, by Region, 2024
Figure 30 : North American Market for Multiomics, by Product, 2021-2029
Figure 31 : North American Market for Multiomics, by Platform, 2021-2029
Figure 32 : North American Market for Multiomics, by Application, 2021-2029
Figure 33 : North American Market for Multiomics, by End User, 2021-2029
Figure 34 : European Market for Multiomics, by Product, 2021-2029
Figure 35 : European Market for Multiomics, by Platform, 2021-2029
Figure 36 : European Market for Multiomics, by Application, 2021-2029
Figure 37 : European Market for Multiomics, by End User, 2021-2029
Figure 38 : Asia-Pacific Multiomics Market Growth Drivers
Figure 39 : Asia-Pacific Market for Multiomics, by Product, 2021-2029
Figure 40 : Asia-Pacific Market for Multiomics, by Platform, 2021-2029
Figure 41 : Asia-Pacific Market for Multiomics, by Application, 2021-2029
Figure 42 : Asia-Pacific Market for Multiomics, by End User, 2021-2029
Figure 43 : Rest of the World Market for Multiomics, by Product, 2021-2029
Figure 44 : Rest of the World Market for Multiomics, by Platform, 2021-2029
Figure 45 : Rest of the World Market for Multiomics, by Application, 2021-2029
Figure 46 : Rest of the World Market for Multiomics, by End User, 2021-2029
Figure 47 : Global Multiomics Market Competitive Intelligence, 2020-2024
Figure 48 : Patents, 2018-2023
Figure 49 : How a Strong ESG Proposition Benefits Businesses
Figure 50 : Biotech Companies Providing ESG Disclosure, 2022
Figure 51 : Location of ESG Disclosure, 2022
Figure 52 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 53 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 54 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 55 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 56 : BD: Revenue Share, by Business Unit, FY 2023
Figure 57 : BD: Revenue Share, by Country/Region, FY 2023
Figure 58 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 59 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 60 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 61 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 62 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 63 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 64 : QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 65 : QIAGEN: Revenue Share, by Country/Region, FY 2023
Figure 66 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 67 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 68 : Standard BioTools: Revenue Share, by Business Unit, FY 2023
Figure 69 : Standard BioTools: Revenue Share, by Country/Region, FY 2023
Figure 70 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 71 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security